TRANSCODE THERAPEUTICS, INC. (RNAZ) Operating income 2020–2025
TRANSCODE THERAPEUTICS, INC. (RNAZ) annual operating income history from SEC filings — each fiscal year as reported.
-$28.0MFY2025 · since FY2020: -$726,604 → -$28.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$28.0M | -78.7% |
| FY2024 | -$15.7M | +19.4% |
| FY2023 | -$19.4M | -4.2% |
| FY2022 | -$18.6M | -202.9% |
| FY2021 | -$6.2M | -746.6% |
| FY2020 | -$726,604 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RNAZ financial trends
RNAZ RevenueRNAZ Net incomeRNAZ Net marginRNAZ Gross profitRNAZ Gross marginRNAZ Operating marginRNAZ Operating cash flowRNAZ Free cash flowRNAZ Capital expendituresRNAZ Return on equityRNAZ Stock buybacksRNAZ Dividends paidRNAZ Total assetsRNAZ Total liabilitiesRNAZ Shareholders’ equityRNAZ overview →